Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Larry D. Anderson, Binod Dhakal, Tania Jain, Olalekan O. Oluwole, Gunjan L. Shah, Surbhi Sidana, Miguel Angel Perales, Marcelo C. Pasquini
Dive into the research topics of 'Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy'. Together they form a unique fingerprint.